MyAverix Finance
F · Healthcare
Vivesto AB (OMAX)
Drug Manufacturers - Specialty & Generic
Vivesto AB (OMAX) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $8.72M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for OMAX
Vivesto AB (OMAX) — FAQ
What is Vivesto AB's market cap?
Vivesto AB (OMAX) has a reported market cap of $8.72M (data as of 2026-03-30).
What is OMAX's P/E ratio?
The price-to-earnings (P/E) ratio for Vivesto AB (OMAX) is 18.00 (data as of 2026-03-30).
Does Vivesto AB pay a dividend?
Dividend yield is not available in the current snapshot for Vivesto AB (OMAX). Check the MyAverix Finance app for the latest dividend data.
What sector is Vivesto AB in?
Vivesto AB (OMAX) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is OMAX listed on?
OMAX is listed on F.
What is Vivesto AB's net margin?
Vivesto AB (OMAX) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.